| 摘要 |
FIELD: medicine; pharmacology. ^ SUBSTANCE: immunogenic hybrid polypeptide includes mimetic peptide of V-cellular epitope of apolypoprotein B-100 in which C-end of mimetic peptide is merged with N-end of T-helper epitope. Amino acid sequences of polypeptide variants are presented in description. Described is method of specified polypeptide production providing application of host cell transformed with recombinant express vector including gene coding specified polypeptide. Besides, invention concerns vaccine composition including specified immunogenic hybrid polypeptide for obesity prevention or treatment, recombinant express vector and host cell. ^ EFFECT: excellent anti-obesity activity without induction of immune response or severe by-effects. ^ 15 cl, 25 dwg, 4 tbl, 15 ex |
